New CDC information on Salmonella Outbreak and Key AR Investments

Having trouble viewing this email? View it as a Web page.

National Center for Emerging and Zoonotic Infectious Diseases

Highlights of our recent work to prevent the spread of infectious diseases


January 2018

Happy New Year from the Center Director

Dr. Rima Khabbaz

It is hard to believe that 2018 is underway! I am excited for the opportunities this year will bring.

Did you know that there are three simple things you can do to stay in-the-know about CDC’s work to prevent and control emerging and zoonotic infectious diseases?

  1. Follow @CDC_NCEZID and me on Twitter
  2. Share this e-mail newsletter with friends, family, and coworkers, and let them know they can sign up for updates too!
  3. Check out our website for the latest on what we do to protect people at home and around the world from emerging and zoonotic infectious diseases.

I wish you a happy, safe, and healthy 2018!

Rima Khabbaz, MD

Director, CDC’s National Center for Emerging and Zoonotic Infectious Diseases


Frozen Shredded Coconut Linked to Outbreak

Frozen shredded coconut bag

CDC and state and federal partners are investigating a multistate outbreak of Salmonella infections linked to frozen shredded coconut.

On January 3, 2018, Evershing International Trading Company recalled all 16 oz. bags of Coconut Tree Brand frozen Shredded Coconut.

CDC recommends retailers not sell, restaurants not serve, and consumers not eat recalled product.

 


Investments to Combat Antibiotic Resistance

Key Investments to Combat Antibiotic Resistance

CDC released new data in its Antibiotic Resistance (AR) Investment Map, which shows early progress by states to combat AR. This year’s AR Investment Map features more than 170 state-reported successes—like rapidly identifying and containing rare and concerning resistant germs to protect communities—with each state reporting multiple successes.

These are the first comprehensive reports on state progress made following the first year of Congress’ unprecedented investment in CDC’s Antibiotic Resistance Solutions Initiative.